The host immunological pathways are re-organized to get a clear picture. There are four acute immune responses: TH1/TH2/TH22/THαβ which are corresponding to four chronic immune responses: TH1Like/TH9/TH17/TH3. Then, the four branches of immune reactions can link to four types of hypersensitivities or allergies. THfh is the stimulatory pathway to initiate adaptive acute immunity. Another inhibitory pathway Treg secreting TGF beta is the key player to shift the above acute immune responses to chronic immune responses for generating milder cytokines and other immune mediators to avoid severe destruction of organ during chronic and large scale of pathogen infection of tissue-organ. This 4x2+2 is the new diagram of host immunological pathways.
Introduction
There are many discovered host immunological pathways including traditional TH1, TH2, TH3, TH17, TH22, THfh, Treg, TH9, and Tr1(THαβ). These identified pathways are not logically organized. Here, I will propose a detailed picture about the whole context of host immunological pathways.
Acute immune responses
The traditional TH1/TH2 paradigm was proposed by Dr. Mosmann in 1986. [1] TH1 was thought the host immunity against viruses and intracellular bacteria. TH2 is the host immunity against multicellular parasites (helminthes). In my PhD thesis, I proposed a new THαβ immunological pathway against viruses that is divided from traditional TH1 immunity. The TH1 immunity is then focusing on intracellular bacteria and protozoa.
Follicular helper T cells (THfh) is thought to be the key helper cells for the B cell
germinal centers in lymph nodes. [2] THfh cells are characterized by IL-21 producing T cells [3; 4] . TGF beta with STAT5 signal can constrain the differentiation of the IL-21 producing helper T cells [5; 6] . IL-21 production is also related to STAT1 and STAT3 activation as well as STAT5 activation. Since immunosuppressive prolactin can induce STAT5a to suppress BCL6 expression. The transcription factor to induce THfh should be STAT5b. BCL6 is key in THfh development. [7; 8; 9 ] Follicular helper T cell can induce B cells to start to produce IgM antibody. [10] Thus, it is the earliest T lymphocytes to begin the adaptive host immunity. [11; 12; 13] Different STAT proteins regulate different immunological pathways. [14] TH1 immunity is driven by IL-12. It is the host immunity against intracellular bacteria or protozoa. The main effector cells of TH1 immunity are stimulatory macrophages (M1), IFNg secreting cytotoxic CD8 T cells (Tc1), IFNg secreting CD4 T cells, and IgG3 producing B cells. [15; 16] The key transcription factors for TH1 immunity is STAT4. Tbet also plays a vital role in TH1 immunological pathway. TH1 immunity against self antigen is Type 4 Delayed type hypersensitivity such as type1 diabetes mellitus. [17] TH2 immunity is driven by IL-4. TH2 immunity is against extracellular parasites (helminthes). The main effector cells of TH2 immunity are eosinophils (iEOS), basophils, mast cells, IL-4/IL-5 secreting CD4 T cells, and IgG4/IgE producing B cells. [18] The key transcription factor for TH2 immunity is STAT6. GATA3 also plays a vital role in TH2 immunological pathway. TH2 immunity against self antigen is Type1
IgE mediated allergy and hypersensitivity such as food/drug allergy or urticaria. [19] THαβ is distinguished from the traditional TH1 immunity [20] . THαβ immunity is against viruses. It was called Tr1 cell by some previous researchers. [21] THαβ immunity is driven by IFNa/b or IL-10. The main effector cells of THαβ immunity are stimulatory NK cells(CD56-CD16+), IL-10/IL-27 secreting CD4 T cells, IL-10 secreting cytotoxic CD8 T cells (Tc2), and IgG1 producing B cells. [15; 22] The key transcription factor for THαβ immunity is STAT1 and STAT2. [23] THαβ immunity against self antigen is Type 3 Antibody dependent cellular cytotoxic hypersensitivity such as acute stage of Myasthenia Gravis. It is worth noting that IL-10 is not merely a immunosuppressive cytokine; it can have potent stimulatory effects on NK cells, CTLs, and B cells. [24] TH22 is the host innate immunity against extracellular bacteria and fungi [25; 26] .
TH22 is driven by IL-6 or TNFa [27; 28] . The main effector cells for TH22 immunity are PMNs, IL-22 secreting CD4 T cells, complements, pentraxins, and IgG2 producing B also important. TGF beta can suppress IL-22 to skew to TH17 immunity. [32] TH22 against self antigen is Type 2 immune-complex and complement mediated hypersensitivity such as Arthus reaction. [33] It is interesting to know that four IgG subtypes fit the four types of acute immunological pathways. Murine IgG antibodies also have four subclasses. There is a correlation between murine and human IgG subtypes: Human IgG1<->Murine IgG2a;
Human IgG2<->Murine IgG3; Human IgG3<->Murine IgG2b; Human IgG4<->Murine IgG1. [34] hIgG1/mIgG2a is against viral antigens; hIgG2/mIgG3 is against bacterial antigen, especially polysaccharides; hIgG3/mIgG2b is against intracellular bacteria; and hIgG4/mIgG1 is related to parasite antigens. [35; 36; 37; 38] Chronic immune responses Treg is the host immune inhibitory mechanism [39] . It is driven by IL-2 and TGF beta.
The main effector cells for Treg are TGFb producing CD4 T cell and IgA producing B cell. The key transcription factor for Treg pathway is STAT5, especially STAT5a. The combination of Treg and the above four immunological pathways is important to shift acute immunity to chronic immunity. During the initial infection, acute stage fierce cytokines can rapidly kill pathogens as well as infected cells or tissues. However, if the pathogen infects a lot of cells in a tissue such as liver, to kill the infected cells will total destroyed the organ. [40] Thus, regulatory T cells STAT5 signal combining TH1/TH2/TH22/THαβ will make CD4 T cells with less fierce cytokines. [41] Then, TH1like/TH9/TH17/TH3 immunological pathways will be generated in chronic stage.
It is worth noting that there are two subtypes of IgA antibodies: IgA1 and IgA2. IgA1 is the dominant IgA antibody in serum, and IgA2 is the dominant IgA in mucosa. TGF beta can induce either IgA1 or IgA2 which seems to be dependent on lymphoid follicle location. [42] In GULTs or Peyer's Patch, IgA2 is the dominant IgA antibody produced in GI mucosa there. In lymph nodes of other body locations, IgA1 is the dominant IgA antibody produced there. [43] However, IgA1 is especially related to viral protein antigens and IgA2 is especially related to bacterial antigens such as LPS. [44] It is also worth noting that IL-13 is also a Treg related cytokine which is profibrogenic and related to TGF beta signaling. [45; 46] TH1-like cells (non-classic TH1) are initiated by TGF beta(STAT5 signaling) and IFNg(STAT4 signaling). TH1-like cells with Foxp3+ regulatory character are 50] TH1-like cells are the chronic host immunity of TH1 immune response. Thus, it could be related to chronic inflammation such as long-term tuberculosis infection.
The effector cells of TH1-like immunity include suppressive macrophages (M2), suppressive CD8 T cells (CD8+CD28-), IgA1 producing B cells, and IFNg/TGFb producing CD4 T cells. [16] TH1-like immunity induces type4 hypersensitivity such as Crohn's disease. [51] TH9 cell is driven by IL-4 (STAT6 signaling) combining TGF beta(STAT5 signaling). 
